Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Paenipeptin analogues potentiate clarithromycin and rifampicin against mcr-1 mediated polymyxin-resistant Escherichia coli in vivo

Antimicrob Agents Chemother. 2020; 
Moon SH, Kaufmann Y, Huang E.
Products/Services Used Details Operation
Peptide Synthesis … 41 Paenipeptin analogues 1 and 15 (>95% purity) are synthetic lipopeptide produced by a 42 commercial peptide synthesis company (Genscript Inc, Piscataway, NJ) Clarithromycin, 43 rifampicin and polymyxin B were purchased from Sigma (St Louis, MO) … Get A Quote

摘要

Polymyxin resistance mediated by mcr-1 gene threatens the last-resort antibiotics. Linear lipopeptide paenipeptin analogues 1 and 15 disrupted the outer membrane of Gram-negative pathogens and potentiated clarithromycin and rifampicin against mcr-1 positive Escherichia coli from the FDA-CDC Antimicrobial Resistance Isolate Bank. In the presence of paenipeptin, clarithromycin and rifampicin resulted in over 3 log reduction of E. coli in vitro Moreover, paenipeptin-antibiotic combinations significantly reduced E. coli in a murine thigh infection model.,Copyright © 2020 American Society for Microbiology.

关键词

XML 地图